Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer

PURPOSE: Circulating tumor DNA (ctDNA) has emerged as a promising tumor-specific biomarker in pancreatic cancer, but current evidence of the clinical potential of ctDNA is limited. In this study, we used comprehensive detection methodology to explore the utility of longitudinal ctDNA measurements in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapin, Morten, Edland, Karin H., Tjensvoll, Kjersti, Oltedal, Satu, Austdal, Marie, Garresori, Herish, Rozenholc, Yves, Gilje, Bjørnar, Nordgård, Oddmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068442/
https://www.ncbi.nlm.nih.gov/pubmed/36662807
http://dx.doi.org/10.1158/1078-0432.CCR-22-3526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068442/
https://www.ncbi.nlm.nih.gov/pubmed/36662807
http://dx.doi.org/10.1158/1078-0432.CCR-22-3526

Ejemplares similares